Morepen Lab. Ltd

MOREPENLAB NSE Healthcare Pharmaceuticals
₹115.78
+0.43%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.17.
  • Comfortable interest cover: operating profit covers interest about 7.9 times.
  • Net profit margin is 5.3%.
  • Pays a dividend (yield about 0.17%).
  • Promoters hold a sizeable stake (35.66%).

!Watch-points

  • Return on equity is on the lower side at 5.3%.
  • Return on capital employed is on the lower side at 8.1%.
  • Profit growth has been slow over five years (about -8% a year).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
3.94

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreWeak
2 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 6,344 Cr
Current Price₹ 115.78
High / Low₹ 122.55 / 33.05
Stock P/E45.226562
Book Value₹ 22.80
Dividend Yield0%
ROCE8.05%
ROE5.33%
Face Value₹ 2.00
Debt to Equity0.17
PEG Ratio3.00
EV / EBITDA40.44
Industry PE35.70
P/B Ratio5.223079
EPS₹ 1.73
Debt₹ 208 Cr
PAT Margin5.32%
Cash PAT₹ 132 Cr
ICR7.88
Promoter Holding35.66%
FII Holding1.46%
DII Holding1.28%
Public Holding61.59%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years 14.00%
5 Years 9.00%
3 Years 8.00%
TTM 9.00%
Compounded Profit Growth
10 Years 14.00%
5 Years -8.00%
3 Years 18.00%
TTM 27.00%
Stock Price CAGR
10 Years 17.00%
5 Years 15.00%
3 Years 46.00%
1 Year 115.00%
Return on Equity
10 Years 12.00%
5 Years 10.00%
3 Years 9.00%
Last Year 5.00%
Educational data only. Not a recommendation to buy, sell or hold any security.